SARS-CoV-2

  • Novel Coronavirus (SARS-CoV-2) Multiplex Real-Time PCR Kit

    Novel Coronavirus (SARS-CoV-2) Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Gida

    Labarin kwaroronavirus shine kwayar RNA, wacce ta kunshi sunadarai da nucleic acid. Kwayar cutar ta mamaye jikin mai gida (ɗan adam), ta shiga cikin ƙwayoyin cuta ta hanyar karɓar mai karɓar mai karɓa ta ACE2, kuma ta kwafa a cikin ƙwayoyin halittar, wanda ke haifar da tsarin garkuwar jiki na mutum don amsawa ga maharan ƙasashen waje da kuma kera wasu ƙwayoyin cuta. Sabili da haka, zazzabin nucleic acid da antigens, da takamaiman abubuwan rigakafi game da littafin coronavirus ana iya amfani dasu bisa ka'ida azaman takamaiman masanan kimiyyar halittu don gano littafin coronavirus. Don gano acidic na nucleic, ana amfani da fasahar RT-PCR sosai.

    Novel Coronavirus (SARS-CoV-2) Multiplex Real-Time PCR Kit an yi amfani da shi don cimma nasarar gano SARS_CoV-2 kwayar RNA da aka ciro daga nasopharyngeal swabs, oropharyngeal swabs, sputum da BALF daga marasa lafiya a haɗuwa da FDA / CE Tsarin cirewa na IVD da kuma dandamali na PCR da aka zayyana a sama.

    An shirya kit ɗin don yin amfani da shi ta ƙwararrun ma'aikata da aka horar

  • SARS-CoV-2 IgM/IgG Antibody Rapid Test

    SARS-CoV-2 IgM / IgG Antibody Rapid Test

    Strongarfin Sarfi®  SARS-CoV-2 IgM / IgG Antibody Rapid Test kit an yi amfani da shi don gwajin ingancin in vitro da kuma gano cutar ta SARS-CoV-2 ta kwayar cutar coronavirus COVID-19 a cikin kwayar cuta / jini / jini gaba daya (gami da jini da jini da yatsan jini) na waɗanda ake zargin marasa lafiya za a iya amfani da ganewar asali na kamuwa da cuta don bincikar mutanen da ke fama da cutar ko kuma masu saurin kamuwa da cutar mai saurin kamuwa da cuta da gwajin ƙwayoyin cuta ko bayanin asibiti.

    Jarabawar tana iyakance a cikin Amurka don rarrabawa zuwa dakunan gwaje-gwaje waɗanda CLIA ta yarda dasu don yin babban gwajin rikitarwa.

    Wannan gwajin ba FDA ta sake nazarin shi ba.

    Sakamako mara kyau baya hana kamuwa da cutar SARS-CoV-2 mai tsanani.

    Ba za a yi amfani da sakamako daga gwajin antibody don tantance ko keɓance mai saurin cutar SARS-CoV-2 ba.

    Sakamako mai kyau na iya zama saboda cutar da ta gabata ko ta yanzu tare da nau'ikan ƙwayoyin cuta na SARS-CoV-2, kamar su coronavirus HKU1, NL63, OC43, ko 229E.

  • SARS-CoV-2 Antigen Rapid Test

    SARS-CoV-2 Antigen Saurin Gwaji

    Ana amfani da Dual Biosafety System Na'urar SARS-CoV-2 Antigen Test don ingancin gano kwayar coronavirus (SARS-CoV-2) antigen nucleocapsid (N) antigen a cikin ɗan adam Throat / Nasopharyngeal swab samfurori a cikin vitro. Ya kamata a yi amfani da kit ɗin kawai azaman mai nuna alama ta gaba ko amfani da shi tare da gano ƙwayoyin nucleic acid a cikin binciken da ake zargi na abubuwan COVID-19. Ba za a iya amfani da shi azaman tushen tushe don ganowa da keɓance marasa lafiyar pneumonitis waɗanda cutar coronavirus ta kamu da su ba, kuma bai dace da tantance yawan jama'a ba. Kayan aikin sun dace sosai don amfani dasu don manyan sikeli a cikin kasashe da yankuna inda sabon kwayar cutar coronavirus ke yaduwa cikin sauri, da kuma samar da ganewar asali da tabbatarwa ga kamuwa da COVID-19.

    MUHIMMANCI: WANNAN KAYAN SANA'AR SUNA NUFIN SHI NE MAI SANA'AR SANA'A KAWAI, BA WAJEN JARRABAWA KO GWADA A GIDA BA!

  • Dual Biosafety System Device for SARS-CoV-2 Antigen Rapid Test

    Dual Na'urar Tsarin Tsaron Halitta don SARS-CoV-2 Antigen Rapid Test

    Ana amfani da Dual Biosafety System Na'urar SARS-CoV-2 Antigen Test don ingancin gano kwayar coronavirus (SARS-CoV-2) antigen nucleocapsid (N) antigen a cikin ɗan adam Throat / Nasopharyngeal swab samfurori a cikin vitro. Ya kamata a yi amfani da kit ɗin kawai azaman mai nuna alama ta gaba ko amfani da shi tare da gano ƙwayoyin nucleic acid a cikin binciken da ake zargi na abubuwan COVID-19. Ba za a iya amfani da shi azaman tushen tushe don ganowa da keɓance marasa lafiyar pneumonitis waɗanda cutar coronavirus ta kamu da su ba, kuma bai dace da tantance yawan jama'a ba. Kayan aikin sun dace sosai don amfani dasu don manyan sikeli a cikin kasashe da yankuna inda sabon kwayar cutar coronavirus ke yaduwa cikin sauri, da kuma samar da ganewar asali da tabbatarwa ga kamuwa da COVID-19. Gwaji yana iyakance ga dakunan gwaje-gwaje da aka tabbatar a ƙarƙashin dokokin ƙasa ko ƙananan hukumomi.

  • System Device for SARS-CoV-2 & Influenza A/B Combo Antigen Rapid Test

    Na'urar tsarin don SARS-CoV-2 & Mura A / B Combo Antigen Rapid Test

    Sarfin Tsarin Tsarin ƙarfi na StrongStep® na SARS-CoV-2 & Mura A / B Combo Antigen Rapid Gwajin yana amfani da gwajin kwayar cutar chromatographic. Akwai hanyoyi guda uku a cikin na'urar da ke gano SARS-CoV-2, nau'in mura da A da kuma na mura a cikin bi da bi, Latex conjugated antibody (Latex-Ab) wanda yayi daidai da SARS-CoV-2 / Mura A / Flu B sun bushe-an kwashe su a ƙarshen kowane tsiri membrane tsiri. SARS-CoV-2 / Mura A / Flu B rigakafi suna haɗuwa a Yankin Gwaji (T) da Biotin-BSA suna haɗin gwiwa a Yankin Sarrafa (C) a kowane tsiri. Lokacin da aka ƙara samfurin, yakan yi ƙaura ta hanyar yaduwar kwayar halitta yana rehydrating lex conjugate. Idan akwai a samfurin, SARS-CoV-2 / Mura A / Flu B antigens zasu ɗaura tare da ƙananan ƙwayoyin cuta masu haɗuwa